530207 — Brawn Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹54.04m
- IN₹40.07m
- IN₹134.65m
Annual cashflow statement for Brawn Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | PRESS |
| Standards: | IAS | IAS | — |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -4.12 | -15.4 | -18 |
| Depreciation | |||
| Non-Cash Items | -0.348 | 0.066 | 0.41 |
| Other Non-Cash Items | |||
| Changes in Working Capital | 6.55 | 14.6 | 16.9 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Accounts Payable | |||
| Change in Taxes Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 3.18 | -0.256 | 0.474 |
| Capital Expenditures | -0.956 | -0.121 | -2.42 |
| Purchase of Fixed Assets | |||
| Cash from Investing Activities | -0.956 | -0.121 | -2.42 |
| Financing Cash Flow Items | -0.082 | -0.038 | -0.037 |
| Other Financing Cash Flow | |||
| Cash from Financing Activities | -0.082 | -0.038 | -0.037 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 2.14 | -0.415 | -1.98 |